As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off

Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But a growing number of researchers, payers, and providers are challenging that consensus and exploring whether — and how — to taper patients off expensive GLP-1 drugs.